Quetiapine hemifumarate

An atypical, second generation antipsychotic compound that has effects at multiple receptors antagonizes dopamine D1, D2, and D3 receptors, serotonin 5-HT1A, 5-HT2A, and 5-HT7 receptors, and &alpha1A, &alpha1B, and &alpha2C adrenergic receptors.

An atypical, second generation antipsychotic compound that has effects at multiple receptors antagonizes dopamine D1, D2, and D3 receptors, serotonin 5-HT1A, 5-HT2A, and 5-HT7 receptors, and &alpha1A, &alpha1B, and &alpha2C adrenergic receptors.

An atypical, second generation antipsychotic compound that has effects at multiple receptors antagonizes dopamine D1, D2, and D3 receptors, serotonin 5-HT1A, 5-HT2A, and 5-HT7 receptors, and &alpha1A, &alpha1B, and &alpha2C adrenergic receptors.

An atypical, second generation antipsychotic compound that has effects at multiple receptors antagonizes dopamine D1, D2, and D3 receptors, serotonin 5-HT1A, 5-HT2A, and 5-HT7 receptors, and &alpha1A, &alpha1B, and &alpha2C adrenergic receptors.

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

Quetiapine hemifumarate

Quetiapine hemifumarate